NCT00726401View on ClinicalTrials.gov

A Randomized, Double-blind, Placebo-controlled Study on the Effect of CVT-E002 in Patients With Seasonal Allergic Rhinitis

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

COLD-fX

200mg BID for 4 weeks

DRUG

Placebo

200mg BID for 4 weeks

Trial Locations (4)

T5N 4A3

Capital Health, Edmonton

L8N 3Z5

McMaster University Medical Centre, Hamilton

M3H 3S3

Melimar Allergy Laboratory, Toronto

M4P 1P2

JDM Research, Toronto

Sponsors
All Listed Sponsors
lead

Afexa Life Sciences Inc

INDUSTRY